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The cell surface of Candida albicans is enriched in highly glycosylated mannoproteins that are involved in the
interaction with the host tissues. N glycosylation is a posttranslational modification that is initiated in the
endoplasmic reticulum (ER), where the Glc3Man9GlcNAc2 N-glycan is processed by -glucosidases I and II
and 1,2-mannosidase to generate Man8GlcNAc2. This N-oligosaccharide is then elaborated in the Golgi to
form N-glycans with highly branched outer chains rich in mannose. In Saccharomyces cerevisiae, CWH41, ROT2,
and MNS1 encode for -glucosidase I, -glucosidase II catalytic subunit, and 1,2-mannosidase, respectively.
We disrupted the C. albicans CWH41, ROT2, and MNS1 homologs to determine the importance of N-oligosac-
charide processing on the N-glycan outer-chain elongation and the host-fungus interaction. Yeast cells of
Cacwh41, Carot2, and Camns1 null mutants tended to aggregate, displayed reduced growth rates, had a
lower content of cell wall phosphomannan and other changes in cell wall composition, underglycosylated
-N-acetylhexosaminidase, and had a constitutively activated PKC-Mkc1 cell wall integrity pathway. They were
also attenuated in virulence in a murine model of systemic infection and stimulated an altered pro- and
anti-inflammatory cytokine profile from human monocytes. Therefore, N-oligosaccharide processing by ER
glycosidases is required for cell wall integrity and for host-fungus interactions.
Candida albicans is an opportunistic fungal pathogen of hu-
mans that can cause superficial infections of the mucosa and, in
the immunocompromised host, life-threatening systemic infec-
tions (10, 52, 53, 61). The cell wall of C. albicans is the imme-
diate point of contact between the fungus and host and there-
fore plays a key role in the host-fungus interaction. The cell
wall is composed of an inner layer of chitin and 1,3- and
1,6-glucans and an outer layer that is rich in mannoproteins
that accounts for 40% of the yeast form cell wall mass (39).
The mannoproteins have important roles in adhesion, antige-
nicity, modulation of the host immune response, and recogni-
tion of this fungus by innate immune cells (4, 9, 11, 49, 56, 67,
78). Therefore, studies of cell wall glycosylation can provide
insights into the molecular basis of the pathogenic and com-
mensal interactions between C. albicans and the human host.
The N-glycosylation pathway has been studied extensively in
Saccharomyces cerevisiae. N glycosylation occurs by a stepwise
process involving the transfer of Glc3Man9GlcNAc2 from
Glc3Man9GlcNAc2-PP-dolichol to specific asparagine residues
of nascent proteins in the endoplasmic reticulum (ER). Sub-
sequently, the Glc3Man9GlcNAc2 core oligosaccharide is pro-
cessed by -glucosidases I and II, which sequentially remove
the terminal 1,2-linked and two remaining 1,3-linked glu-
cose residues, respectively. Further processing by ER 1,2-
mannosidase I generates Man8GlcNAc2 isomer B (27, 28). In
the Golgi compartment, Och1 initiates the outer-chain branch-
ing of N-glycans by the addition of a single 1,6-linked man-
nose residue to Man8GlcNAc2 core. In the och1 null mutant
of C. albicans, the Man8GlcNAc2 N-glycan core is subjected to
further modification with three to eight mannose residues
added to one or more of the antenna residues of the core (4).
The 1,6-mannose backbone of the N-mannan outer chain is
extended by the enzyme complexes mannan polymerase I and
II, and branched side chains are attached by a range of Golgi
mannosyltransferases to yield a high-mannose N-glycan that
may represent 95% of the glycoprotein mass (15, 39, 47).
Studies of glycosylation pathways in C. albicans are important
because key differences exist between the O- and N-glycan
structures of this fungus and S. cerevisiae. For example, in C.
albicans, the terminal mannose residues of O-glycans are at-
tached by 1,2-linkages rather than 1,3-mannose residues as
in S. cerevisiae (46), and 1,2-linked mannose residues are
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present in both the acid-labile and acid-stable N-glycans (64,
73). Such changes are likely reflected in surface-to-surface
interactions of these organisms in their natural environments
and during human infection.
In S. cerevisiae, CWH41 (GLS1), ROT2 (GLS2), and MNS1
encode three ER enzymes: -glucosidase I, -glucosidase II
catalytic subunit, and 1,2-mannosidase, respectively, which
are involved in N-glycan core processing (27). Cwh41 removes
the outermost 1,2-glucose residue of Glc3Man9GlcNAc2 be-
fore it is trimmed further by -glucosidase II, which removes
the 1,3-glucose residues from Glc2Man9GlcNAc2 (23, 62, 76).
In S. cerevisiae, the -glucosidase II is a heterodimer with the
catalytic -subunit encoded by ROT2, a member of the glycosyl
hydrolase family 31. In higher eukaryotes the -subunit nor-
mally contains a KDEL-type ER retention motif (74). In lower
eukaryotes such as fungi, no gene with significant homology to
the -subunit has been found. Mns1 is an 1,2-mannosidase
that trims the Man9GlcNAc2 oligosaccharide to Man8GlcNAc2
isomer B, the last product of the N-glycan processing carried
out in the ER (8, 34). It has been suggested that removal of this
unique mannose residue induces a conformational reorganiza-
tion in the N-glycan core that is required for the outer-chain
synthesis (8). The core-processing -glycosidases are also im-
portant for glycoprotein folding and for the ER quality control
during glycoprotein biosynthesis (24, 29).
Recent studies in C. albicans have shown that protein gly-
cosylation is essential for fungal pathogenesis and immune
recognition. Mannosyltransferases involved in N- and O-linked
glycosylation have been shown to be required for virulence (4,
7, 46, 54, 66, 69, 70). Golgi proteins involved in the provision of
GDP-mannose for glycosylation, which are encoded by
CaVRG4 and CaSRB1, are essential for this fungus, indicating
the overall importance of glycosylation to cell viability (26, 51,
79, 80). Also, CaPmr1, a Golgi P-type Ca2/Mn2-ATPase
involved in the transport of Ca2 and Mn2 ions into the Golgi
compartment, is necessary for normal O- and N-linked glyco-
sylation and virulence (3). However, cell wall phosphomannan
synthesis is apparently not required for full virulence (30).
To assess the importance of N-oligosaccharide processing
and N-mannan structure on the host-fungus interaction, we
disrupted the C. albicans CWH41, ROT2, and MNS1 homologs.
The null mutants displayed a number of cell wall defects, were
attenuated in virulence in a murine model of systemic infec-
tion, and stimulated an altered cytokine profile by human pe-
ripheral blood mononuclear cells (PBMC). Therefore, N-oli-
gosaccharide processing by ER -glycosidases to generate
high-mannose N-glycans is vital for the host-fungus interaction
and for virulence.
MATERIALS AND METHODS
Strains, media, and culture conditions. All of the strains used and constructed
in the present study are listed in Table 1. Strains were grown at 30°C in YPD
medium (1% [wt/vol] yeast extract, 2% [wt/vol] mycological peptone, 2% [wt/vol]
glucose) or in SD medium (0.67% [wt/vol] yeast nitrogen base with ammonium
sulfate without amino acids, 2% [wt/vol] glucose, 0.077% [wt/vol] complete
supplement mixture minus uracil [Qbiogene, Cambridge, United Kingdom]) with
uridine (50 g/ml) as required. Hyphal cells were grown in YPD medium plus
20% (vol/vol) newborn calf serum, Lee’s medium (pH 6.5) (41), or salt base
(0.45% [wt/vol] NaCl, 0.335% [wt/vol] yeast nitrogen base with ammonium sul-
fate without amino acids, 2.5 mM GlcNAc) (16) at 37°C or on solid Spider
medium (43) at 30°C. To induce -N-acetylhexosaminidase (HexNAcase) syn-
thesis, cells were grown in SCGlcNAc (0.67% [wt/vol] yeast nitrogen base with
ammonium sulfate without amino acids, 0.077% [wt/vol] complete supplement
mixture minus uracil, 25 mM GlcNAc) at 30°C. For virulence assays, the inoc-
ulum of yeast cells was grown in NGY medium (0.1% [wt/vol] neopeptone, 0.4%
[wt/vol] glucose, and 0.1% [wt/vol] yeast extract) at 30°C.
Construction of null mutants and control strains. The MNS1, ROT2, and
CWH41 genes were disrupted by the “mini-ura-blaster” protocol (81). To make
the disruption cassette, long primers containing 70-pb 5 and 3 regions of the
open reading frames were used to amplify by PCR the dp1200-URA3-dp1200




TABLE 1. Strains used in this study
Strain Parent strain Genotype Source or reference
CAI4 CAF2-1 ura3::imm434/ura3::imm434 22
NGY152 CAI4 Same as CAI4 but RPS1/rps1::CIp10 6
HMY1 CAI4 Same as CAI4 but MNS1/mns1::dp1200-URA3-dp1200 This study
HMY2 HMY1 Same as CAI4 but MNS1/mns1::dp1200 This study
HMY3 HMY2 Same as CAI4 but mns1::dp1200/mns1::dp1200-URA3-dp1200 This study
HMY4 HMY3 Same as CAI4 but mns1::dp1200/mns1::dp1200 This study
HMY5 HMY4 Same as CAI4 but mns1::dp1200/mns1::dp1200, RPS1/rps1::CIp10 This study
HMY6 HMY4 Same as CAI4 but mns1::dp1200/mns1::dp1200, RPS1/rps1::CIp10-MNS1 This study
HMY7 HMY2 Same as CAI4 but MNS1/mns1::dp1200, RPS1/rps1::CIp10 This study
HMY8 CAI4 Same as CAI4 but ROT2/rot2::dp1200-URA3-dp1200 This study
HMY9 HMY8 Same as CAI4 but ROT2/rot2::dp1200 This study
HMY10 HMY9 Same as CAI4 but rot2::dp1200/rot2::dp1200-URA3-dp1200 This study
HMY11 HMY10 Same as CAI4 but rot2::dp1200/rot2::dp1200 This study
HMY12 HMY11 Same as CAI4 but rot2::dp1200/rot2::dp1200, RPS1/rps1::CIp10 This study
HMY13 HMY11 Same as CAI4 but rot2::dp1200/rot2::dp1200, RPS1/rps1::CIp10-ROT2 This study
HMY14 HMY9 Same as CAI4 but ROT2/rot2::dp1200, RPS1/rps1::CIp10 This study
HMY15 CAI4 Same as CAI4 but CWH41/cwh41::dp1200-URA3-dp1200 This study
HMY16 HMY15 Same as CAI4 but CWH41/cwh41::dp1200 This study
HMY17 HMY16 Same as CAI4 but cwh41::dp1200/cwh41::dp1200-URA3-dp1200 This study
HMY18 HMY17 Same as CAI4 but cwh41::dp1200/cwh41::dp1200 This study
HMY19 HMY18 Same as CAI4 but cwh41::dp1200/cwh41::dp1200, RPS1/rps1::CIp10 This study
HMY20 HMY18 Same as CAI4 but cwh41::dp1200/cwh41::dp1200, RPS1/rps1::CIp10-CWH41 This study
HMY21 HMY16 Same as CAI4 but CWH41/cwh41::dp1200 RPS1/rps1::CIp10 This study










GTTTTTAGCTGTTTTCCCAGTCACGACGTT-3; the regions complemen-
tary to plasmid pDDB57 are underlined. The genes were disrupted by sequential
rounds of transformation of strain CAI4 and the recycling of the URA3 marker
by selection on SD medium plus 5-fluoroorotic acid (1 mg/ml) and uridine. To
avoid the problems associated with the ectopic expression of URA3 (6), the Ura
mns1, rot2, and cwh41 null strains were transformed with StuI-digested
CIp10 plasmid (48); hence, URA3 was expressed at the RPS1 locus. To construct
reintegrant control strains, the MNS1 open reading frame plus 999 bp of its
promoter and 597 bp of its terminator sequences (total of 3.3 kb) and ROT2 (979
bp of promoter and 693 bp of terminator [total of 4.3 kb]) and CWH41 (946 bp
of promoter and 593 bp of terminator [total of 4.0 kb]) genes were amplified by
PCR (primer pair for MNS1, 5-GCGGCCGCTAAGATCAACTTTTTTCTAT
TC-3 and 5-GCGGCCGCAATGATACCAATAAGGA-3; primer pair for
ROT2, 5-GCGGCCGCAATCTTATTAGCTCCAGAC-3 and 5-GCGGCCG
CATACCGTACCAAGAAA-3; and primer pair for CWH41, 5-GCGGCCGC
TTATCTAGACAAATGTTTAAAAT-3 and 5-GCGGCCGCTTAGATACT
GAACGTCATT-3, with the bases to generate a NotI site underlined), and the
products were cloned into pGEM-T Easy vector (Promega, Ltd., Southampton,
United Kingdom). The inserts were released by NotI digestion and subcloned
into the NotI site of CIp10. The resulting plasmids were digested with StuI and
used to transform the Ura null strains. As a further control, strain CAI4 was
transformed with StuI-digested CIp10. Therefore, all strains analyzed had the
URA3 marker expressed at the RPS1 locus.
Assay of -glycosidase activity. The -mannosidase and -glucosidase activi-
ties were measured by using fluorogenic substrates as described previously (45,
71). Cells were collected by low-speed centrifugation, washed twice with 50 mM
sodium phosphate buffer (pH 6.0) (buffer A), and broken with glass beads using
a FastPrep machine (Qbiogene), and the homogenate was centrifuged at 21,500 
g for 10 min. The supernatant obtained was subjected to ultracentrifugation at
105,000  g for 1 h, and the high-speed supernatant and the mixed membrane
fraction were collected, freeze-dried, and kept at 20°C until use. Fractions (10
to 100 g of protein) were incubated at 37°C with 40 M MUMan or MUGlc
and buffer A for assay of -mannosidase or -glucosidase, respectively, in a final
volume of 200 l. After 30 min, the reaction was stopped by adding 3.3 ml of 50
mM glycine-NaOH buffer (pH 11.0), and the fluorescence of 4-methylumbellif-
erone (MU) was read in a spectrofluorometer with excitation and emission set at
350 and 440 nm, respectively. Specific activity was expressed as nmoles of MU
liberated per minute per milligram of protein (1 U 	 1 nmol of MU). Total
activity is referred as units of specific activity liberated by the total protein of the
preparations.
Sensitivity testing. Strains that were tested for sensitivity to specific cell-wall-
perturbing agents were initially grown for 24 h in YPD medium and then washed
with water and resuspended at an optical density at 600 nm (OD600) of 1.0. These
cells were inoculated into YPD medium at an OD600 of 0.01, and 95-l aliquots
were spotted into microdilution plate wells. Test agents in 5-l volumes were
added at a range of doubling dilutions. Duplicate plates were incubated for 16 h
at 30°C, and the OD600 was determined. The agents tested were Calcofluor
White (100 g/ml), Congo red (100 g/ml), 0.1% sodium dodecyl sulfate (SDS),
hygromycin B (500 g/ml), salts (NaCl and KCl at 1 M), caffeine (50 mM), and
tunicamycin (100 g/ml).
Alcian Blue binding assays. Alcian Blue affinity assays for phosphomannan
content were carried out as described previously (4, 30). Assays were also per-
formed on -eliminated cells that were stripped of O-glycans, by overnight
treatment with 100 mM NaOH at room temperature and subsequent washing of
the cells with water.
Analysis of the cell wall composition. Yeast cells were grown in YPD medium
at 30°C and broken as described above. The homogenate was centrifuged at
1,000  g for 10 min, and the pellet, containing the cell debris and walls, was
washed with 1 M NaCl, resuspended in buffer (500 mM Tris-HCl buffer [pH 7.5],
2% [wt/vol] SDS, 0.3 M -mercaptoethanol, 1 mM EDTA), boiled for 10 min,
and freeze-dried. The -glucan, mannan, and chitin levels were determined by
hydrolysis of those polymers and quantification of glucose, mannose, and gluco-
samine, respectively. For quantification of glucose and mannose, cell walls were
resuspended in 2 M trifluoroacetic acid, boiled for 3 h, washed, and centrifuged
at 21,500  g for 10 min. The hydrolysates were analyzed by high-performance
anion-exchange chromatography as described previously (45). For the determi-
nation of chitin content, the cell walls were hydrolyzed and analyzed as described
previously (37). For total protein determination, cell walls were resuspended in
1 N NaOH, boiled for 30 min, neutralized with 1 N HCl, and assayed by using the
method described by Bradford (5).
In situ -N-acetylhexosaminidase activity staining. Zymograms of native poly-
acrylamide gel electrophoresis (PAGE) were assayed as reported previously (4).
After the growth for 16 h in SC plus GlcNAc, the cells were washed, resuspended
in 10 mM Tris-HCl buffer (pH 8.0) containing protease inhibitor cocktail
(Roche, Lewes, United Kingdom), and broken with glass beads in a FastPrep
machine, and the homogenate was centrifuged at 21,500  g for 10 min. For
deglycosylation treatment, the native sample was incubated with 25 mU of
endoglycosidase H (Roche) for 16 h at 37°C in 50 mM sodium acetate buffer (pH
5.2). Samples were mixed with native loading dye (62.5 mM Tris-HCl buffer [pH
6.8], 0.01% [wt/vol] bromophenol blue, and 15% [vol/vol] glycerol) and run on a
3 to 8% Tris-acetate PAGE gel (Invitrogen, Paisley, United Kingdom) for 1 h at
19 V/cm under nondenaturing conditions. The gel was washed in 0.1 M citrate-
KOH buffer (pH 4.0) for 10 min at room temperature and then incubated in the
substrate solution (0.18 mM naphthyl-GlcNAc [Glycosynth, Ltd., Warrington,
United Kingdom] in 0.1 M citrate-KOH buffer [pH 4.0]) for 30 min at 37°C. The
reaction product was visualized by incubation in the substrate solution plus 0.7
mM Fast Blue at 60°C until color developed.
Protein extracts and Western blotting. To test for activation of the cell integ-
rity pathway, cells were grown in YPD medium at 30°C and collected in mid-
exponential growth phase. As positive controls, strains were stressed by the
addition of Calcofluor White (100 g/ml) 2 h before collection. Cells were
washed, resuspended in extraction buffer (100 mM Tris-HCl buffer [pH 7.5],
0.01% [wt/vol] SDS, 1 mM dithiothreitol, 10% [wt/vol] glycerol, protease inhib-
itor mixture [Roche]), and broken with glass beads in a FastPrep machine, and
the lysate was centrifuged at 21,500  g for 10 min. Then, 50 g of protein was
separated on a 4 to 12% NuPAGE Bis-Tris gel (Invitrogen) and electrotrans-
ferred to a polyvinylidene difluoride membrane. The membrane was blocked in
phosphate-buffered saline plus 0.1% Tween 20 and 5 mg of bovine serum albu-
min/ml for 2 h at room temperature. Detection was then carried out with the
PhosphoPlus p44/42 mitogen-activated protein kinase (Thr202/Tyr204) antibody
kit (Cell Signaling Technology, Hertfordshire, United Kingdom), which cross-
reacts with C. albicans Mkc1 (Slt2) in both its active (phosphorylated) and
inactive (nonphosphorylated) forms.
Stimulation of cytokine production in human monocytes. Isolation of human
PBMC was performed as described elsewhere (20). Samples of 5  105 PBMC
in a 100-l volume were added to round-bottom 96-well plates (Greiner, Alphen
a/d Rijn, The Netherlands) and incubated with 100 l of various strains of
heat-killed (30 min at 56°C) C. albicans yeast cells at a concentration 106 cells/ml.
After 24 h of incubation at 37°C, the PBMC-C. albicans cell suspensions were
centrifuged; supernatants were collected and stored at 70°C until assayed.
Human tumor necrosis factor alpha (TNF-) concentrations were determined by
specific radioimmunoassays as described previously (19). Interleukin-6 (IL-6)
and IL-10 concentrations were measured by commercial enzyme-linked immu-
nosorbent assay kits (Pelikine Compact; Sanquin, Amsterdam, The Nether-
lands). The experiments were performed in duplicate with samples from four
volunteers. The differences between strains were analyzed by using the Student
t test, and the level of significance was set at P 
 0.05.
Virulence tests. Female, immunocompetent BALB/c mice (Harlan Sera-Lab,
Ltd., Loughborough, United Kingdom) were challenged intravenously with
yeasts grown for 18 to 24 h in NGY medium at 30°C. The cells were washed twice
with water and resuspended in physiological saline to give a challenge inoculum
of 1.8  104 CFU/g of mouse body weight in a 100-l volume. For mutants with
attenuated growth in vitro, virulence attenuation in vivo was confirmed in groups
of two mice intravenously inoculated and monitored over 21 days. Mice showing
signs of illness were humanely terminated, and their deaths recorded as occur-
ring the following day.
Nucleotide sequence accession numbers. The CaCWH41 and CaMNS1 se-
quences have been submitted to GenBank and were assigned accession numbers
DQ295807 and AY167027, respectively.
RESULTS
Isolation, analysis, and deletion of CaCWH41, CaROT2, and
CaMNS1. The analysis of C. albicans genome databank iden-
tified two DNA fragments as the 5 and 3 ends of CaCWH41
(GenBank accession XM_718516 and XM_705221, respec-
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tively). To identify the complete coding sequence, primers
aligning in the 5 and 3 of the putative open reading frame
were used to amplify CaCWH41, and the fragment was cloned
and sequenced. The CaCWH41 open reading frame of 2,493 bp
(GenBank/EBI accession no. DQ295807) is predicted to en-
code a protein of 830 amino acids showing homology to other
-glucosidase I enzymes of the glycosyl hydrolase family 63
(60% homology to Cwh41 from S. cerevisiae). The predicted
protein had a characteristic type II membrane protein domain
structure with a single 20-amino-acid transmembrane region at
the N terminus and a 2-amino-acid cytosolic tail. CaCwh41
includes a 606ELNVDLISW614 sequence similar to substrate
binding motifs reported in vertebrate enzymes (58). Residues
Ser421, Arg467, and Gly717 are homologous to those in human
-glucosidase I, which are necessary for catalytic activity (29,
31, 77).
CaROT2 was identified in the C. albicans genome (36) by
homology to the S. cerevisiae homologue. The CaROT2 open
reading frame of 2,616 bp (GenBank accession no.
XM_711779) is predicted to encode a protein of 871 amino
acids of the glycosyl hydrolase family 31 that is between 57 and
38% identical to other fungal and mammalian Rot21 proteins
(61% homology to Rot2 from S. cerevisiae). Again, this se-
quence was typical of a type II membrane protein, having a
predicted 2-amino-acid cytosolic tail and a 20-amino-acid
transmembrane region. The glycosyl hydrolase family 31 mem-
bers contain a short peptide segment of conserved amino acids
(DGXWIDMNEXSXF), including a conserved Asp residue
that is thought to be involved in catalysis (25, 32, 33, 38, 72).
A similar peptide sequence (487IHLWNDMNEPSVF499) is
present in CaRot2, indicating that this protein also belongs to
the same protein family. Consistent with its putative role in
N-glycan processing, CaRot2 contains the motif HDEL in the
C-terminal region responsible for the receptor-mediated re-
trieval of a number of ER proteins from the Golgi compart-
ment (68).
The CaMNS1 open reading frame of 1,698 bp (GenBank/
EBI accession no. AY167027) is predicted to encode a protein
of 565 amino acids with significant homology to other ER
glycosyl hydrolase family 47 members (65% homology to Mns1
from S. cerevisiae). This protein is 71 and 42% identical to
Mns1 from fungi and mammals, respectively, and also had a
characteristic type II membrane protein structure with one
cytosolic amino acid and 22 amino acids in the membrane
region of the N-terminal domain. Conserved catalytic and
metal ion coordinating amino acid residues typical of ER 1,2-
mannosidases are present. These include Cys320 and Cys363 cor-
responding to ScMns1 Cys340 and Cys385, which are necessary for
stabilization of the tertiary structure of the catalytic pocket (42),
and Arg251, which would be predicted to be required for the
specificity of the ER 1,2-mannosidase reaction (59).
The CaCWH41, CaROT2, and CaMNS1 genes were dis-
rupted in strain CAI4 by sequential gene replacement using
the mini-ura-blaster protocol (81). The resulting Cacwh41
(HMY-19), Carot2 (HMY-12), and Camns1 (HMY-5) null
mutants (Table 1) had URA3 reintroduced at the neutral RSP1
locus to avoid problems due to ectopic expression of URA3 (6,
48). Reintegrant control strains were also constructed in which
CaCWH41, CaROT2, or CaMNS1 were introduced into the
null strains under the control of their own promoters at the
RPS1 locus. Strain CAI4 transformed with CIp10 was used as
a control in all experiments and is referred as the parent strain,
equivalent to the wild type.
Growth and morphology of the null mutants. The Cacwh41,
Carot2, and Camns1 null mutants had reduced specific growth
rates in YPD medium at 30°C of 0.44, 0.47, and 0.56 h1 respec-
tively, compared to the parent strain (0.69 h1). The reintegrant
controls had specific growth rates identical to that of the parent
strain. Yeast cells of the three null mutants tended to form small
aggregates, and Cacwh41 and Carot2 yeast cells were swollen
and enlarged (Fig. 1A) and small and crenulated (Fig. 1B) colo-
nies. The Camns1 null mutant grew as normal hyphae in 20%
(vol/vol) serum, GlcNAc-containing medium, and Lee’s medium
at pH 6.5, while the Carot2 and Cacwh41 null mutants had
delayed filamentation and formed shorter and swollen germ tubes
with decreased extension rates (data not shown). All three null
mutants failed to induce filaments on solid Spider medium (Fig.
1C). In all cases the mutant phenotypes were fully complemented
by reintegration of a wild-type copy of the respective gene.
The null mutants have altered -glycosidase activities. The
-glucosidase or -mannosidase activities in the null mutants
were determined by using the fluorogenic substrates 4-methylum-
bellyferyl--D-glucopyranoside (MUGlc) or 4-methylumbelly-
feryl--D-mannopyranoside (MUMan), respectively. Homoge-
nates of Cacwh41 and Carot2 null mutants had total
-glucosidase activities of 48 and 51%, respectively, compared
to the total activity present in wild-type cells (Table 2). Com-
FIG. 1. Cell and colony morphology in the Cacwh41, Carot2,
and Camns1 null mutants. (A) Cell morphology after growth at 30°C
for 16 h in YPD medium, demonstrating clumping of cells in the
Cacwh41 (HMY19), Carot2 (HMY12), and Camns1 (HMY5) null
mutants. Scale bars, 10 m. (B and C) Colony morphology after 5 days
growth at 30°C on YPD agar plates (B) or solid Spider medium (C).
Scale bars, 1 mm.
TABLE 2. -Glucosidase activity in Cacwh41 and Carot2 null
mutants and reintegrant strains
Strain genotype




WT 35  1 55  3 45  3
Cacwh41 17  0.3 99  1 1  1
Cacwh41  CaCWH41 28  0.4 57  3 43  3
Carot2 18  0.3 2  1 98  1
Carot2  CaROT2 28  1 42  3 58  3
a Expressed as nmol of MU min1 total protein1 (n 	 3).
b Expressed as a percentage of the total activity.
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plemented reintegrant controls recovered the wild-type activ-
ity. In wild-type cells, the -glucosidase activity was distributed
equally between the soluble and mixed membrane fractions. It
was demonstrated previously that the soluble activity corre-
sponds to -glucosidase II (71). As predicted, the Cacwh41
null mutant had no measurable membrane-associated -gluco-
sidase activity, whereas Carot2 null mutant lacked soluble
-glucosidase activity (Table 2). No measurable -mannosi-
dase activity was found in soluble fraction or mixed membrane
preparations of the Camns1 null mutant (data not shown).
Glycosylation defects. We determined the consequences of
the alteration in N-glycan structure in Cacwh41, Carot2, and
Camns1 null mutants by measuring changes in the electro-
phoretic mobility of secreted HexNAcase in native gels us-
ing an in situ activity assay (4). HexNAcase, encoded by
CaHEX1, is induced in media containing GlcNAc as the sole
carbon source and has been demonstrated to be highly N
glycosylated (12, 44, 50). The HexNAcase from Cacwh41,
Carot2, and Camns1 null mutants had an increased elec-
trophoretic mobility. Mutants lacking -glucosidase I and II
had the greater mobility, indicating a more severe N-glyco-
sylation defect than in Camns1 null mutant (Fig. 2). The
electrophoretic mobility of HexNAcase of the reintegrant
controls under inducing conditions was similar to wild type.
After endoglycosidase H treatment to remove N-glycans,
the HexNAcase of all mutant and parent strains migrated
faster and with the same mobility (data not shown).
In C. albicans most of the acid-labile phosphomannan frac-
tion is attached to N-linked mannan (30). Phosphomannan
accounts for the negative charge of the cell wall, and this binds
the cationic dye Alcian Blue. The Cacwh41, Carot2, and
Camns1 null mutants bound 17.7, 18.5, and 41.1% of the
Alcian Blue bound by the parent strain, respectively (Table 3).
The reintegrant controls showed the wild-type levels of Alcian
Blue bound. When the Alcian Blue binding assay was carried
out after elimination of O-glycans by -elimination, the phos-
phomannan levels in the Carot2 and Cacwh41 null mutants
decreased from 17.7 and 18.5% to 3.2 and 3.9%, respectively
(Table 3), indicating that the N-glycan phosphomannan resi-
dues were almost completely absent in these -eliminated null
mutants strains. These results indicate that CaCWH41 and
CaROT2 have an important role in N-glycan outer-chain elab-
oration.
Cell wall composition, sensitivity, and cell integrity pathway
activation. To determine the effect of the disruption of
CaCWH41, CaROT2, and CaMNS1 on the overall cell wall
composition, the content of total carbohydrates, and proteins
was analyzed. Cacwh41 and Carot2 null mutants showed
decreases of 30.4 and 29.7% and of 65.0 and 62.9% in the
contents of glucan and mannan, respectively (Table 4). Also,
an increase in the chitin and protein levels of 2.2- and 3.3-fold
for the Cacwh41 null mutant and of 2.2- and 3.2-fold for the
Carot2 null mutant was observed. Camns1 null mutant had
an increase of 10.2, 16.9, and 53.0% in the content of glucan,
chitin, and proteins, respectively (Table 4). These changes
were reflected in an overall decrease of 51.4% in the mannan
levels. The reintegrant controls had cell wall compositions sim-
ilar to that of wild-type yeast cells.
To investigate the effect of the ER -glycosidase loss on the
integrity of the cell wall, we tested the null mutants for their
sensitivity to a range of cell-wall-perturbing agents and
other compounds associated with glycosylation defects. The
Camns1 null mutant was hypersensitive to Congo red, Cal-
cofluor White, and hygromycin B, and Carot2 and Cacwh41
null mutants were hypersensitive to Calcofluor White, Congo
red, hygromycin B, tunicamycin, and SDS (Fig. 3). Hypersen-
FIG. 2. N-glycosylation defects in Cacwh41, Carot2, and
Camns1 null mutants. The electrophoretic mobility of -N-acetylhex-
osaminidase under nondenaturing conditions was examined. The
strains tested include NGY152 (wild type), HMY19 (Cacwh41),
HMY20 (Cacwh41  CaCWH41), HMY12 (Carot2), HMY13
(Carot2  CaROT2), HMY5 (Camns1), and HMY6 (Camns1 
CaMNS1).
TABLE 3. Alcian Blue binding of Cacwh41, Carot2, and
Camns1 null mutants and reintegrant strains
Strain genotype
Mean Alcian Blue binding  SDa
No treatment After -elimination
WT 111  5 95  6
Cacwh41 20  3 3  2
Cacwh41  CaCWH41 109  5 92  5
Carot2 21  5 4  3
Carot2  CaROT2 108  8 91  4
Camns1 46  5 29  4
Camns1  CaMNS1 109  7 92  5
a Expressed as g bound/OD600 	 1 cells (n 	 3).
TABLE 4. Cell wall composition of Cacwh41, Carot2, and
Camns1 null mutants and reintegrant strains
Strain genotype
Mean amt (g) of polymer  SDa
Glucan Mannan Chitin Protein
WT 546  11 276  15 18  2 140  7
Cacwh41 380  14 97  11 41  2 459  6
Cacwh41  CaCWH41 591  17 246  11 18  1 124  8
Carot2 384  10 102  13 40  2 444  8
Carot2  CaROT2 561  15 277  12 17  1 120  7
Camns1 602  15 134  13 21  2 215  6
Camns1  CaMNS1 581  14 258  15 18  4 128  10
a That is, per mg of cell wall dry weight (n 	 3).
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sitivity to these agents is shared by other N-glycosylation mu-
tants of S. cerevisiae and C. albicans (2–4, 14). There were no
changes in the sensitivity to other stress-inducing agents such
as caffeine, NaCl, or KCl (data not shown). The walls of the
null mutants were therefore sensitive to cell wall stress but not
to osmotic stress. We tested whether the PKC-Mkc1 cell in-
tegrity pathway was activated in the null mutants by Western
analysis with an antibody that recognizes the phosphorylated
form of the Mkc1 mitogen-activated protein kinase (17). Mkc1
was activated in the Cacwh41, Carot2, and Camns1 null
mutants but not in the wild type and reintegrant controls (Fig.
4). As a positive control, the strains were stressed with 100 g
of Calcofluor White/ml, which is known to activate the path-
way. These results reinforce the conclusion that N-mannan
processing glycosidases are required for the assembly of a
normal robust cell wall.
N-mannan processing is required for a pathogenic host-
fungus interaction. It has been demonstrated previously that
the N-linked mannosyl residues of the C. albicans cell wall are
involved in its recognition by monocyte and macrophages and
in the induction of proinflammatory and anti-inflammatory
cytokines by these mononuclear cells of the innate immune
system (49). Therefore, cytokine production by human PBMC
was investigated after stimulation by yeast cells of the
Cacwh41, Carot2, and Camns1 mutants. In the Cacwh41
null mutant stimulation of TNF, IL-6, and IL-10 was reduced
by 62, 70, and 90%, respectively (Fig. 5). Similar results were
obtained with the Carot2 null mutant, with levels of TNF,
FIG. 3. Sensitivity of Cacwh41, Carot2, and Camns1 null mutants to cell-wall-perturbing agents. Wild type (Œ), null mutants (E), and
reintegrant controls (F) strains were tested for sensitivity to cell-wall-perturbing agents by using the microdilution method. The strains tested were
the Cacwh41 (HMY19) (A), Carot2 (HMY12) (B), and Camns1 (HMY5) (C) null mutants. Error bars indicate the means  the standard
deviation (n 	 3). The results are pooled data from duplicate experiments.
FIG. 4. Activation of the cell integrity pathway in glycosidase null mutants assessed by Western analysis. Protein extracts were prepared from
cells in mid-exponential phase. As a positive control for activation of the cell integrity pathway, the strains were treated with Calcofluor White (100
g/ml) as indicated. Extracts are from the following strains: NGY152 (wild type), HMY19 (Cacwh41), HMY20 (Cacwh41  CaCWH41),
HMY12 (Carot2), HMY13 (Carot2  CaROT2), HMY5 (Camns1), and HMY6 (Camns1  CaMNS1). Equal loading was confirmed by
Ponceau S staining and determining the intensity of nonspecific bands.
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IL-6, and IL-10 reduced by 63, 66, and 95%, respectively (Fig.
5). Normal cytokine release was recovered in the respective
reintegrant controls. TNF, IL-6, and IL-10 levels stimulated by
the Camns1 null mutant were not statistically different (P 	
0.1001, P  0.5, and P  0.5, respectively) from those stimu-
lated by wild-type cells (Fig. 5). In order to determine whether
the changes in the cell wall of the null mutants led to exposure
of elements present in the inner layers such as the -glucans,
human PBMC were treated with laminarin before the chal-
lenge with the yeast cells to block signaling via the -glucan/
dectin-1 receptor system (49). For the wild-type cells, there was
a small but statistically insignificant decrease in the stimulation
of TNF. A similar reduction was observed in the null mutants
and reintegrants control tested (Fig. 5A). The results indicate
that recognition of the Cacwh41, Carot2, and Camns1 null
mutants by the dectin-1 receptor was not a significant factor in
the recognition of these stains under these conditions.
The effect of the N-mannan processing -glycosidase loss
encoded by CaCWH41, CaROT2, and CaMNS1 on virulence
was assessed in a mouse model of systemic infection. Because
mutants with reduced growth rates are usually attenuated in
virulence, we simply confirmed the virulence loss in a systemic
mouse model using only duplicate mice. The Cacwh41,
Carot2, and Camns1 null mutants were highly attenuated in
virulence with a mean survival time of 21 days, compared to 5.5
days for the wild-type control (data not shown). Virulence was
restored in the reintegrant controls, which displayed mean
survival times similar to the wild-type cells. Therefore, normal
N-glycan processing is essential for pathogenesis and a normal
host-fungus interaction and virulence.
DISCUSSION
In this study, we describe the importance of N-glycan pro-
cessing for normal N glycosylation, structure, and integrity of
the C. albicans cell wall and for interaction with the host. The
Glc3Man9GlcNAc2 N-oligosaccharide is processed by ER
-glycosydases to generate the Man8GlcNAc2 core, which is a
substrate for Golgi mannosyltransferases in charge of the
highly branched outer-chain elaboration (27). Previous studies
have demonstrated the importance of glycosylation for the cell
wall structure, adherence, and virulence (3, 4, 7, 30, 46, 51, 54,
60, 69, 70, 80). For N-mannans, the N-glycan outer-chain elon-
gation is necessary for the assembly of a normal cell wall
structure and for virulence (4). We have extended these studies
by analyzing the importance of N-glycan processing. Accord-
ingly, we disrupted the C. albicans homologs of CWH41, ROT2,
and MNS1 genes of S. cerevisiae, which encode the ER -glu-
cosidase I, the catalytic subunit of -glucosidase II and -man-
nosidase I, respectively. The Carot2 and Cacwh41 null mu-
tants had defects in the N-glycan outer-chain elongation,
evidenced by the loss of cell wall phosphomannan and in-
creased mobility of HexNAcase, and had a weakened cell wall.
Null mutants were strongly affected in virulence and in their
ability to induce cytokine production by PBMC. These defects
were similar but less dramatic than those displayed by
Caoch1 null mutant, which lacks the entire N-glycan outer
chain (4). The Camns1 null mutant had a milder phenotype
than the Cacwh41 and Carot2 null mutants, in terms of
specific growth rate, phosphomannan content, HexNAcase
mobility, and cell wall integrity, but was still significantly af-
fected in virulence and had an altered cytokine induction pro-
file. Therefore,-mannan processing is important for the host-
fungus interaction of C. albicans, but alterations in core-
mannan production at different steps resulted in different
phenotypes.
We previously demonstrated, using the fluorogenic substrate
MUMan, that C. albicans 1,2-mannosidases belong to the
glycosyl hydrolase family 47 and are present in both soluble
and membrane-bound forms (45; H. M. Mora-Montes et al.,
unpublished data). The total absence of -mannosidase activ-
ity in the Camns1 null mutant indicates that CaMNS1 is likely
to encode both the soluble and the membrane-bound activities.
The absence of soluble -glucosidase activity in the Carot2
null mutant agrees with previous studies indicating that in C.
FIG. 5. Cytokine stimulation by Cacwh41, Carot2, and Camns1 null mutants. Human PBMC were stimulated 24 h with 106 yeast cells/ml
and the TNF (A) and IL-6 and IL-10 (B) concentrations were determined. The experiments for panel A were carried out in the absence () or
presence (f) of laminarin, a blocking agent of the -glucan/dectin-1 recognition pathway. The strains tested are NGY152 (wild type), HMY19
(Cacwh41), HMY20 (Cacwh41  CaCWH41), HMY12 (Carot2), HMY13 (Carot2  CaROT2), HMY5 (Camns1), and HMY6 (Camns1 
CaMNS1). The results are pooled data from four volunteers. Error bars indicate the means  the standard deviation. *, Significant differences in
the mutant compared to the wild type (P 
 0.05).
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albicans the -glucosidase II activity is associated with a solu-
ble 47-kDa polypeptide (71). Because the molecular mass of
this soluble protein is lower than that predicted for CaRot2, it
is possible that the -glucosidase II activity is processed by a
protease to generate a soluble catalytic domain.
The Cacwh41, Carot2, and Camns1 null mutants had 36,
32, and 19% reductions, respectively, in the growth rate of the
yeast form. This contrasts with previous reports in S. cerevisiae,
wherein no defects on the growth rates were observed in mu-
tants lacking -glucosidase I or II (21, 74). Yeast cells of the
Cacwh41, Carot2, and Camns1 null mutants tended to
clump as small aggregates. Aggregation may be the result of
changes in the cell wall hydrophobicity due to decreased
charged phosphomannan content. Alternatively, clumping may
be the result of a cell separation defect due to alterations in the
activity of glycosylated cell wall hydrolases that participate
in cytokinesis. A similar clumping phenotype has been re-
ported for other C. albicans glycosylation mutants such as
the Camnt1/Camnt2 (46), Capmr1 (3), Caoch1 (4),
Camnn9 (66), and Cavrg4 (51) null mutants.
Evidence was found for defects in N glycosylation in
the three null mutants generated. This was more severe in the
Cacwh41 and Carot2 null mutants, as demonstrated by the
underglycosylation of HexNAcase. HexNAcase is exclusively N
glycosylated, is readily detected in nondenaturing PAGE gels,
and has been used as a sensitive marker of N-glycosylation
defects (4). Loss of CaCWH41 or CaROT2 resulted in defects
in N glycosylation demonstrated by the increased mobility of
HexNAcase and a reduction in N-glycan-linked phosphoman-
nan content of the cell wall. The remaining phosphomannan
present in the null mutants was attached to O-mannan and
could be removed by -elimination. A similar result was ob-
served in the Caoch1 null mutant, where the N-glycan outer-
chain elongation is blocked (4). Therefore, the presence of
glucose residues on the N-glycan core may inhibit the ability of
the CaOch1 1,6-mannosyltransferase to initiate the outer-N-
chain elongation. The absence of -glucosidase I activity in S.
cerevisiae did not prevent outer-chain formation or the addi-
tion of 1,3-mannose residues to the core oligosaccharides
(75), suggesting that the importance of the N-glycan core glu-
cose residues for subsequent outer-chain elongation may be
different in C. albicans and S. cerevisiae. The N-glycosylation
defect in Camns1 null mutant was not as severe as in Carot2
and Cacwh41 null mutants, indicating that partial elongation
of the N-glycan core occurred. This indicates that the removal
of mannose from the N-glycan core is not required for outer-
chain synthesis, as found in S. cerevisiae (55).
The Cacwh41, Carot2, and Camns1 null mutants had an
altered and weakened cell wall, as demonstrated by changes in
cell wall composition and hypersensitivity to a range of cell-
wall-perturbing agents and other agents whose action is indic-
ative of glycosylation defects. The consequences of CaCwh41,
CaRot2, or CaMns1 loss resulted in the constitutive activation
of the PKC-Mkc1 cell integrity pathway. A similar result was
observed in other C. albicans null mutants with defects in
glycosylation (3, 4, 14). Similar observations have been made
for S. cerevisiae, where the lack -glucosidase I or II leads to
alterations in the cell wall composition (35, 63, 65). The
Camns1 null mutant was least affected by cell-wall-perturbing
agents, correlating with a milder N-glycosylation mutant phe-
notype. Disruption of CaCWH41 and CaROT2 resulted in a
30% reduction in the cell wall -glucan content, but loss of
CaMNS1 did not affect the levels of this polymer. This suggests
that proteins involved in the biosynthesis of -glucans are
sensitive to changes in the N-glycosylation pathway. However,
C. albicans och1 mutants that lack N-glycan outer chain do
not have reduced -glucan levels (4). This suggests that the
-glucan reduction in the walls of Cacwh41 and Carot2 null
mutants may be due to a failure in the glycoprotein quality
control/protein refolding pathways that are dependent on glu-
cosylation of the N-mannan core rather than the shortening of
the N-glycan outer chain. Indeed, it has been demonstrated in
S. cerevisiae that the presence of glucose residues on the N-
mannan core led to an instability of Kre6, a protein required
for 1,6-glucan biosynthesis, resulting in decreased levels of
1,6-glucan in the cell wall (1). There was also no change in
sensitivity to high salt conditions in the three null mutants,
indicating that the mutants were not osmotically fragile and
that the SDS sensitivity of the Cacwh41 and Carot2 null
mutants is likely to be the result of the cell wall perturbation
rather than effects on the plasma membrane.
The Cacwh41, Carot2, and Camns1 mutants were sig-
nificantly attenuated in virulence in a mouse model of systemic
infection, as has been demonstrated for other C. albicans N-
glycosylation null mutants (4, 66).
The balance of pro- and anti-inflammatory response is
known to be important for the outcome of a number of fungal
infections (13, 18, 40, 57). Decreased levels of TNF, IL-6, and
IL-10 were observed with human PBMC challenged with
Cacwh41 and Carot2 null mutants. This finding is in agree-
ment with the observation that approximately 70% less cyto-
kine production was stimulated in PBMC by the Caoch1 null
mutant (49). The disruption of CaMNS1 did not affect the
release of IL-6 and IL-10 but did result in increased release of
TNF. This suggests that IL-6 and IL-10 may be stimulated by
a different cell wall epitope than that which activates PBMC to
release TNF. These effects on cytokine production are not
likely to be mediated via the dectin-1 receptor since laminarin-
treated PBMC gave similar responses to untreated PBMC in
all cases. Therefore, N-glycan core processing is vital to the cell
wall architecture of C. albicans, to its pathogenesis, and for
host-fungus interactions.
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